LifePoint Health Reports Second Quarter 2016 Results

Go back to LifePoint Health Reports Second Quarter 2016 Results

Wedbush Cuts Price Target on LifePoint Health (LPNT) to $66 Following 2Q; Reiterates Neutral

August 1, 2016 8:06 AM EDT

Wedbush maintained a Neutral rating on Lifepoint Holdings (NASDAQ: LPNT), and cut the price target to $66.00 (from $80.00), following the company's 2Q.

Analyst Sarah James commented, "Admission trends have been disappointing across the board for hospitals. The drivers seem relatively company specific in... More

Mizuho Securities Remains Neutral as LifePoint Health (LPNT) Trades Below Previous Target - PT to $56

August 1, 2016 7:06 AM EDT

Mizuho Securities maintained a Neutral rating on Lifepoint Holdings (NASDAQ: LPNT), and cut the price target to $56.00 (from $61.50), following the company's 2Q. Mizuho attributes the company's recent trade down and guide cut to one-time issues involving a flawed too-rapid acquisition strategy.

Analyst Sheryl... More

LifePoint Health (LPNT) Misses Q2 EPS by 19c, Guidance Falls Short

July 29, 2016 8:12 AM EDT

LifePoint Health (NASDAQ: LPNT) reported Q2 EPS of $0.71, $0.19 worse than the analyst estimate of $0.90. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.61 billion.

GUIDANCE:

LifePoint Health sees FY2016 EPS of $3.43-$3.70, versus the consensus of... More